

Intramuscular Injector Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global intramuscular injector market is projected to reach a value of $3.5 billion by 2026, with a CAGR of 6.4% during the forecast period. The market is primarily driven by the increasing prevalence of chronic diseases and the rising demand for injectable drugs. North America dominates the market due to advanced healthcare infrastructure and high adoption of intramuscular injectors. Request Sample Report
◍ Antares Pharma
◍ Endo International Plc
◍ Bioject Medical Technologies
◍ PharmaJetMedical International Technology
◍ National Medical Products
◍ Valeritas
◍ European Pharma Group
◍ PenJet Corporation
◍ Becton
◍ Dickinson
◍ Injex Pharma AG
◍ Crossject SA
◍ Solace Biotech
◍ Sanify Healthcare Private Limited
◍ Novosanis
◍ Vata
◍ Kaleo
The competitive landscape of the intramuscular injector market includes Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJet, National Medical Products, and more. These companies offer innovative injector technologies to enhance drug delivery efficiency. Sales revenue figures for some companies: Antares Pharma - $135 million, Endo International Plc - $2.92 billion.
◍ Hospitals
◍ Clinics
◍ Ambulatory Surgery Centers
◍ Others
◍ Pre-fillable Injection System
◍ Fillable Needle-free Injectors
Request Sample Report
$ 3.50 Billion
Request Sample Report